Renal effects of norepinephrine in septic and nonseptic patients

Chest

Volumn 126, Issue 2, 2004, Pages 534-539

  Albanèse, Jacques ^a   Leone, Marc ^a   Garnier, Franck ^a   Bourgoin, Aurélie ^a   Antonini, François ^a   Martin, Claude ^a,b  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^b HÔPITAL NORD   (France)

Author keywords

Kidney; Norepinephrine; Renal blood flow; Septic; Shock

Indexed keywords

NORADRENALIN;

ADULT; AGED; ARTERIAL PRESSURE; ARTICLE; BRAIN PERFUSION; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HEAD INJURY; HEART INDEX; HEMODYNAMICS; HUMAN; KIDNEY FUNCTION; MALE; MICTURITION; PRIORITY JOURNAL; SEPTIC SHOCK; URBAN AREA; VASCULAR RESISTANCE; VASOCONSTRICTION;

EID: 4143078161     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.126.2.534     Document Type: Article

References (32)

1. Bone RC, Balk BA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis: the ACCP/SCCM Consensus Conference Committee; American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101:1644-1655
2. Schreuder WO, Schneider AJ, Groeneveld ABJ, et al. Effect of dopamine vs norephinephrine or dopamine for the treatment of hyperdynamic septic shock? Chest 1989; 95:1282-1288
3. Martin C, Papazian L, Perrin G, et al. Norepinephrine or dopamine for the treatment of hyperdynamic septic shock. Chest 1993; 103:1826-1831
4. Dasta JF. Norepinephrine in septic shock: renewed interest in an old drug. DICP 1990; 24:153-156
5. Martin C, Viviand X, Leone M, et al. Effects of norepinephrine on the outcome of septic shock. Crit Care Med 2000; 28:2758-2765
6. Mayer J, Skelton J, Mills L. Norepinephrine: effect in normal subject; use in treatment of shock unresponsive to other measures. Ann J Med 1953; 15:330-343
7. Chesnut RM. Secondary brain insults after head injury: clinical perspectives. New Horiz 1996; 3:366-375
8. Bullock RN, Chesnut RM, Clifton G, et al. Guidelines for the management of severe head injury. Eur J Emerg Med 1996; 2:109-127
9. Rosner MJ, Rosner SD, Johnson AH. Cerebral perfusion pressure: management protocol and clinical results. J Neurosurg 1995; 83:949-962
10. Myburgh JA, Lewis SB. Goal-directed therapy in neurotrauma. In: Vincent JL, ed. Yearbook of intensive care and emergency medicine. Berlin, Germany: Springer Verlag, 1996; 716-730
11. Ract C, Vigué B. Comparison of the cerebral effects of dopamine and norepinephrine in severely head-injured patients. Intensive Care Med 2001; 27:101-106
12. Bellomo R, Kellum JA, Winiewski SR, et al. Effects of norepinephrine on the renal vasculature in normal and endotoxemic dogs. Am J Respir Crit Care Med 1999; 159: 1186-1192
13. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31-37
14. Cronin RA, Erickson M, De Torrente A, et al. Norepinephrine-induced acute renal failure: a reversible ischemic model of acute renal failure. Kidney Int 1978; 14:187-190
15. Schott CA, Gray GA, Stoclet JC. Dependance of endotoxin-induced vascular hyporeactivity on extracellular L-arginine. Br J Pharmacol 1993; 108:38-43
16. Lilbourn RO, Gross SS, Jubran A, et al. N-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide. Proc Natl Acad Sci USA 1990; 87:3629-3632
17. Bellomo R, Di Giantomaso D. Noradrenaline and the kidney: friends or foes? Crit Care 2001; 5:294-298
18. Desjars P, Pinaud M, Potel G, et al. A reappraisal of norepinephrine therapy in human septic shock. Crit Care Med 1987; 15:134-137
19. Meadows D, Edwards JD, Wilkins RG, et al. Reversal of intractable septic shock with norepinephrine therapy. Crit Care Med 1988; 16:663-666
20. Martin C, Eon B, Saux P, et al. Renal effects of norepinephrine used to treat septic shock patients. Crit Care Med 1990; 18:282-285
21. Desjars P, Pinaud M, Bugnon D, et al. Norepinephrine therapy has no deleterious renal effects in human septic shock. Crit Care Med 1990; 18:1048-1049
22. Rudis MI, Basha MA, Zarowitz BJ. Is it time to reposition vasopressors and inotropes in sepsis? Crit Care Med 1996; 24:525-537
23. Redl-Wenzel EM, Armbruster C, Edelmann G, et al. The effects of norepinephrine on hemodynamics and renal function in severe septic shock states. Intensive Care Med 1993; 19:151-154
24. Cronin RE, De Torrente A, Miller PD, et al. Pathogenic mechanisms in nearly norepinephrine induced acute renal failure: functional and histological correlates of protection. Kidney Int 1978; 14:115-125
25. Anderson WP, Korner PI, Selig SE. Mechanisms involved in the renal responses to intravenous and renal artery infusions of noradrenaline in conscious dogs. J Physiol 1981; 321:21-30
26. Zhang H, Smail N, Cabral A, et al. Effects of norepinephrine on regional blood flow and oxygen extraction capabilities during endotoxemic shock. Am J Respir Crit Care Med 1997; 155:1965-1971
27. Schaer GL, Fink MP, Parillo JE. Norepinephrine alone versus norepinephrine plus low-dose dopamine: enhanced renal blood flow with combination pressor therapy. Crit Care Med 1985; 13:492-496
28. Mills LC, Mover JH, Handley CA. Effects of various sympathomimetic drugs on renal hemodynamics in normotensive and hypotensive dogs. Am J Physiol 1960; 198:1279-1285
29. Practice guidelines for pulmonary artery catheterization. Anesthesiology 2003; 99:988-1014
30. Bartal C, Danon A, Schlaeffer F, et al. Pharmacokinetic dosing of aminoglycosides: a controlled trial. Ann J Med 2003; 114:194-198
31. Buijk SE, Mouton JW, Gyosens IC, et al. Experience with a once-daily dosing program of aminoglycosides in critically ill patients. Intensive Care Med 2002; 28:936-942
32. Cerebral perfusion pressure. Crit Care Med 2003; 31:S447-S449